GlassScriptPhysician profile
Danielle B Groves
NPI 1679580823
$2,389.19
in general payments reported to CMS, 2019-2025
44 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $506 · 2021: $348 · 2022: $428 · 2023: $366 · 2024: $307 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774 · Education: $16.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.45 |
| Education | $16.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $251.40 | 2019-2021 | |
| Abbott Laboratories | $228.47 | 2020-2022 | |
| Ferring Pharmaceuticals INC. | $157.94 | 2019-2021 | |
| Asensus Surgical, INC. | $108.66 | 2022-2024 | Senhance |
| Depuy Synthes Sales INC. | $107.74 | 2020-2021 | |
| Stratus Medical, LLC | $104.96 | 2023 | Nimbus |
| Scilex Pharmaceuticals INC. | $95.46 | 2019-2020 | |
| Nevro Corp. | $93.78 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $84.02 | 2022-2025 | Lagevrio, Dificid |
| Boston Scientific Corporation | $64.98 | 2019-2021 | |
| Glaxosmithkline, LLC. | $58.59 | 2022-2023 | Trelegy Ellipta, Shingrix, Bexsero |
| Amgen INC. | $58.35 | 2022-2023 | Prolia, Evenity |
| Collegium Pharmaceutical, INC. | $56.70 | 2023-2024 | Belbuca |
| Janssen Biotech, INC. | $52.66 | 2022-2025 | Tremfya |
| Horizon Therapeutics Plc | $49.82 | 2019-2021 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Groves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.